Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:

‍

Expanding its medical device business, Johnson & Johnson announced plans to purchase Abiomed for about $17 billion in cash. Abiomed makes the Impella heart-pump devices that increase the rate of blood flow. (Fortune)

A new light-activated coating for medical devices helps fights bacterial infections, developed by Georgios Sotiriou and his research team at the Karolinska Institute in Sweden. (Medical Xpress)

Meanwhile, a clinical trial at the Mayo Clinic is testing a new device that may eliminate needle sticks for diabetes patients. (KTTC News)

The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team AG Mednet will be there!

‍

‍

‍

Our Culture

“Dossiers and redaction are built within the Judi platform, which helps significantly with adjudication management—and the client collaborates on the process.”

 –Jess, Program Manager‍
‍
‍

‍‍

‍

‍

About Judi

Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.